Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis
Gestational diabetes is on the rise globally, and is linked to a wide range of complications in for mom and baby in the short and long-term. Half of all women with gestational diabetes will go on to develop type 2 diabetes. GDm-Health was designed to help improve outcomes for women with gestational diabetes and reduce the overall cost of care.
Fewer appointments with diabetes specialists
Fewer premature births among women with gestational diabetes
Fewer Caesarean sections among women with gestational diabetes
Patient and clinician satisfaction
In the UK, GDm-Health is used across 64 NHS trusts. Over half of all women with gestational diabetes in the UK are on GDm-Health
GDm-Health was co-developed with a team of researchers at Oxford University and has been evaluated in a randomised controlled trial and multiple real-world evidence studies
Patients use a Bluetooth-connected blood glucose meter and log on to the GDm-Health app (iOS, Android) and to track their blood glucose readings.
Care teams use the web-based portal to design care pathways for patients with gestational diabetes, monitor their blood glucose readings in real time and identify those who need care escalation.
number of NHS Trusts using GDm-Health
Cumulative total of patients since August 2018
Patient users each month
Clinician users every month
Women who use GDm-Health until delivery